Ventas, Inc. (VTR) EBITDA
The ebitda for Ventas, Inc. (VTR) is $2.24 Billion with a year-over-year change of +15.60%. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) measures a company's operating performance by removing non-cash charges and capital structure effects.
VTR EBITDA Chart
Current EBITDA
$2.24B
$2.24 Billion
Year-over-Year Change
+15.60%
vs. $1.94B prior year
Historical Data
30
Years of data available
Annual EBITDA History
| Year | EBITDA | YoY Change | % Change |
|---|---|---|---|
| 2025 | $2.24B | +$302.06M | +15.60% |
| 2024 | $1.94B | $-12.46M | -0.64% |
| 2023 | $1.95B | +$328.70M | +20.28% |
| 2022 | $1.62B | $-96.13M | -5.60% |
| 2021 | $1.72B | $-228.09M | -11.73% |
| 2020 | $1.94B | +$41.42M | +2.18% |
| 2019 | $1.90B | +$103.64M | +5.76% |
| 2018 | $1.80B | $-148.03M | -7.60% |
| 2017 | $1.95B | $-2.45M | -0.13% |
| 2016 | $1.95B | +$136.25M | +7.51% |
| 2015 | $1.81B | +$109.84M | +6.45% |
| 2014 | $1.70B | +$115.05M | +7.24% |
| 2013 | $1.59B | +$170.47M | +12.02% |
| 2012 | $1.42B | +$417.71M | +41.74% |
| 2011 | $1.00B | +$391.27M | +64.20% |
| 2010 | $609.50M | +$30.63M | +5.29% |
| 2009 | $578.87M | $-5.32M | -0.91% |
| 2008 | $584.19M | +$34.59M | +6.29% |
| 2007 | $549.60M | +$150.56M | +37.73% |
| 2006 | $399.04M | +$86.93M | +27.85% |
| 2005 | $312.11M | +$99.12M | +46.54% |
| 2004 | $212.99M | +$53.80M | +33.79% |
| 2003 | $159.19M | $-11.88M | -6.95% |
| 2002 | $171.07M | $-14.01M | -7.57% |
| 2001 | $185.09M | $-6.17M | -3.23% |
| 2000 | $191.26M | +$13.32M | +7.49% |
| 1999 | $177.93M | +$36.92M | +26.18% |
| 1998 | $141.01M | $-310.05M | -68.74% |
| 1997 | $451.07M | +$303.53M | +205.73% |
| 1996 | $147.54M | — | — |
About Ventas, Inc.
As an S&P 500 company, Ventas operates strategically at the nexus of the dynamic healthcare and real estate industries. We stand as one of the world's foremost Real Estate Investment Trusts (REITs), utilizing financial capital to unlock property value. Our partnerships extend to leading care providers, developers, research and medical institutions, innovators, and healthcare organizations, all of whom benefit from the significant demographic trend of an aging population. For over two decades, Ventas has pursued a steadfast and effective strategy: maintaining a high-quality, diverse portfolio of assets and varied capital streams to skillfully navigate market fluctuations. A dedicated and experienced team collaborates with industry-leading partners to generate consistent, increasing cash flows and superior returns on a strong balance sheet, ultimately enriching Ventas's shareholders. As of September 30, 2020, Ventas either owned outright or managed through unconsolidated joint ventures approximately 1,200 properties.
- Sector
- Real Estate
- Industry
- REIT - Healthcare Facilities
- CEO
- Debra A. Cafaro